Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice
暂无分享,去创建一个
L. Fleisher | S. Virani | D. Wijeysundera | K. Fleischmann | J. Washam | C. Nkonde-Price | Dallas Duncan | D. Duncan
[1] Biykem Bozkurt,et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[2] P. Austin,et al. Duration of preoperative β-blockade and outcomes after major elective noncardiac surgery. , 2014, The Canadian journal of cardiology.
[3] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[4] G. Mashour,et al. Perioperative Metoprolol and Risk of Stroke after Noncardiac Surgery , 2013, Anesthesiology.
[5] W. Beattie,et al. Selective &bgr;1-Antagonism with Bisoprolol Is Associated with Fewer Postoperative Strokes than Atenolol or Metoprolol: A Single-center Cohort Study of 44,092 Consecutive Patients , 2013, Anesthesiology.
[6] J. Mayet,et al. Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery , 2013, Heart.
[7] W. Henderson,et al. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. , 2013, JAMA.
[8] Deepak L. Bhatt,et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[9] G. Guyatt,et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.
[10] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[11] Denis Xavier,et al. Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.
[12] G. Guyatt,et al. Prognostic Value of Troponin and Creatine Kinase Muscle and Brain Isoenzyme Measurement after Noncardiac Surgery: A Systematic Review and Meta-analysis , 2011, Anesthesiology.
[13] A. Wallace,et al. Perioperative &bgr;-Blockade: Atenolol Is Associated with Reduced Mortality When Compared to Metoprolol , 2011, Anesthesiology.
[14] W. S. Beattie,et al. Chronic &bgr; Blockade Is Associated with a Better Outcome after Elective Noncardiac Surgery than Acute &bgr; Blockade: A Single-center Propensity-matched Cohort Study , 2011, Anesthesiology.
[15] Jeroen J. Bax,et al. Timing of pre-operative Beta-blocker treatment in vascular surgery patients: influence on post-operative outcome. , 2010, Journal of the American College of Cardiology.
[16] A. Wallace,et al. Association of the Pattern of Use of Perioperative &bgr;-Blockade and Postoperative Mortality , 2010, Anesthesiology.
[17] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[18] H. Calkins,et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. , 2009, Journal of the American College of Cardiology.
[19] J Fortún,et al. Ca-125: A Useful Marker to Distinguish Pulmonary Tuberculosis from Other Pulmonary Infections , 2009, The open respiratory medicine journal.
[20] P. Devereaux,et al. The experts debate: Perioperative beta-blockade for noncardiac surgery—proven safe or not? , 2009, Cleveland Clinic Journal of Medicine.
[21] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[22] Jeroen J. Bax,et al. Bisoprolol and Fluvastatin for the Reduction of Perioperative Cardiac Mortality and Myocardial Infarction in Intermediate-Risk Patients Undergoing Noncardiovascular Surgery: A Randomized Controlled Trial (DECREASE-IV) , 2009, Annals of surgery.
[23] B. Gersh. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2009 .
[24] E. Boersma,et al. β blockers in non-cardiac surgery: haemodynamic data needed , 2008, The Lancet.
[25] W. Berry,et al. An estimation of the global volume of surgery: a modelling strategy based on available data , 2008, The Lancet.
[26] Qi Wang,et al. [Effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease undergoing non-cardiac surgery]. , 2008, Zhonghua yi xue za zhi.
[27] M. Schermerhorn,et al. Sex-related differences in outcome after high-risk vascular surgery after the administration of beta-adrenergic-blocking drugs. , 2008, Journal of cardiothoracic and vascular anesthesia.
[28] Denis Xavier,et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.
[29] J. Ornato,et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov , 2007, Circulation.
[30] M. Hersberger,et al. Adrenergic Receptor Genotype but Not Perioperative Bisoprolol Therapy May Determine Cardiovascular Outcome in At-risk Patients Undergoing Surgery with Spinal Block: The Swiss Beta Blocker in Spinal Anesthesia (BBSA) Study: A Double-blinded, Placebo-controlled, Multicenter Trial with 1-Year Follow-up , 2007, Anesthesiology.
[31] G. Maurer,et al. Perioperative &bgr;-Blockers for Preventing Surgery-Related Mortality and Morbidity: A Systematic Review and Meta-Analysis , 2007 .
[32] H. Calkins,et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Gui , 2006, Anesthesia and analgesia.
[33] G. Maurer,et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. , 2007, Anesthesia and analgesia.
[34] Homer Yang,et al. The effects of perioperative β-blockade: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial , 2006 .
[35] Roger M Harbord,et al. A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints , 2006, Statistics in medicine.
[36] P. L. Petersen,et al. Effect of perioperative β blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial , 2006, BMJ : British Medical Journal.
[37] J. Earnshaw,et al. Lessons learned from a randomised controlled study of perioperative beta blockade in high risk patients undergoing emergency surgery. , 2006, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.
[38] Wen‐qi Huang,et al. [Beneficial effects of metoprolol on perioperative cardiac function of elderly esophageal cancer patients]. , 2006, Ai zheng = Aizheng = Chinese journal of cancer.
[39] A. Sutton,et al. Comparison of two methods to detect publication bias in meta-analysis. , 2006, JAMA.
[40] Homer Yang,et al. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. , 2006, American heart journal.
[41] Gordon H. Guyatt,et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk , 2005, Canadian Medical Association Journal.
[42] P. Lindenauer,et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. , 2005, The New England journal of medicine.
[43] Gordon H Guyatt,et al. How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials , 2005, BMJ : British Medical Journal.
[44] J. Powell,et al. Regarding "Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial". , 2005 .
[45] D. Redelmeier,et al. Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study. , 2005, BMJ.
[46] M. Sydes,et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. , 2005, Journal of vascular surgery.
[47] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[48] R. Stevens,et al. Pharmacologic Myocardial Protection in Patients Undergoing Noncardiac Surgery: A Quantitative Systematic Review , 2003, Anesthesia and analgesia.
[49] E. Antman,et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluati , 2002, Journal of the American College of Cardiology.
[50] E. Antman,et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluat , 2002, Circulation.
[51] E. Antman,et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluati , 2002, Circulation.
[52] Jeroen J. Bax,et al. The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery , 2000 .
[53] P. Kligfield,et al. Postoperative Prophylactic Administration of &bgr;-Adrenergic Blockers in Patients at Risk for Myocardial Ischemia , 2000, Anesthesia and analgesia.
[54] Jeroen J. Bax,et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.
[55] D. Reich,et al. Beneficial Effects from β-Adrenergic Blockade in Elderly Patients Undergoing Noncardiac Surgery , 1999 .
[56] E F Cook,et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.
[57] Farris K. Timimi,et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. , 1999, Anesthesia and analgesia.
[58] D. Massel,et al. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. , 1999, The Annals of thoracic surgery.
[59] D. Reich,et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. , 1999, Anesthesiology.
[60] C. Jakobsen,et al. Perioperative metoprolol reduces the frequency of atrial fibrillation after thoracotomy for lung resection. , 1997, Journal of cardiothoracic and vascular anesthesia.
[61] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[62] A. Wallace,et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.
[63] R. Gibbons,et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). , 1996, Journal of the American College of Cardiology.
[64] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.